Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.30
Delayed Data
As of 4:05pm ET
 +0.08 / +0.97%
Today’s Change
7.81
Today|||52-Week Range
19.43
-46.81%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close8.22
Today’s open8.15
Day’s range7.81 - 8.35
Volume151,808
Average volume (3 months)1,057,722
Market cap$1.2B
Data as of 4:05pm ET, 11/30/2021

Growth & Valuation

Earnings growth (last year)-6.00%
Earnings growth (this year)-47.07%
Earnings growth (next 5 years)+14.14%
Revenue growth (last year)+15.39%
P/E ratioNM
Price/Sales17.75
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
BNGOBionano Genomics Inc-0.03-0.76%
OCGNOcugen Inc-0.08-1.24%
RGNXRegenxbio Inc+1.86+6.16%
AXSMAxsome Therapeutics ...+0.17+0.50%
Data as of 4:57pm ET, 11/30/2021

Financials

Next reporting dateMarch 3, 2022
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$118.2M
Annual profit (last year)-$121.0M
Net profit margin-102.37%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Brisbane, California

Forecasts